Well, this is the last Monday newsletter of 2020. For that, we are thankful.
We will be winding down and taking some deep breaths this week as we gear up for a big 2021 with loads on the docket. We’ll be sharing what we have in store next year in January.
For now, stay safe and stay distant.
Read on…
Special Purpose Acquisition Corporations are all the rage in cannabis these days. But US securities regulators are considerably less keen. Regulators are asking SPACs to up their transparency game. (Funny, John Prentice asked for something similar in September…) MJ Biz Daily johnprentice.ca
Please read my statement here:https://t.co/aFXPM8n7Cb https://t.co/J6iFmIxDoZ
— 🏴☠️John X. Prentice🏴☠️ (@JohnaldPrentice) September 1, 2020
The DEA has issued new rules to allow for more research cannabis growers. Our friends at US law firm Saul Ewing Arnstein and Lehr take a look at what it means. Saul.com
To Israel…
Recreational cannabis could become legal in Israel – Matt Lamers at MJ Biz Daily looks at the roadmap of how that could happen. MJ Biz Daily
Back at home…
As you may recall, Health Canada is the midst of a public consultation asking for feedback on what might need changes in the Cannabis Act. Yahoo! Finance took a look at what might change. Yahoo! Finance
To the courts…
Canopy is suing GW Pharma on a patent infringement (for a method of extraction). MJ Biz Daily
Get your popcorn ready!! 🍿 $OILS $OILFF https://t.co/xQbnIOD8aD
— Paul Pedersen (@paul_oils) December 23, 2020
While we’re in Smith Falls, Ontario… Canopy and the VC firm Canopy Rivers are breaking up. Newswire
SUPER EXCITED! @CanopyRiversInc announced a transaction that monetizes our investments in three portfolio assets for a total transaction value of ~$297M, representing an aggregate ROIC of ~5.6x and IRR of ~101%. Info: https://t.co/BEooSJusRm$RIV $CNPOF
— Narbe Alexandrian (@narbe87) December 21, 2020
During the holidays, it is a good time to release information you would rather not get wide publicity. Health Canada is taking this to heart. Opening up a public consultation over the holidays (see above) and releasing data on cannabis patients. Newswire